Literature DB >> 30767058

Graded murine wire-induced aortic valve stenosis model mimics human functional and morphological disease phenotype.

Sven Thomas Niepmann1, Eva Steffen2, Andreas Zietzer2, Matti Adam3, Julia Nordsiek2, Isabella Gyamfi-Poku4, Kerstin Piayda4, Jan-Malte Sinning2, Stephan Baldus3, Malte Kelm4,5, Georg Nickenig2, Sebastian Zimmer2, Christine Quast4.   

Abstract

Aortic valve stenosis (AS) is the most common valve disease requiring therapeutic intervention. Even though the incidence of AS has been continuously rising and AS is associated with significant morbidity and mortality, to date, no medical treatments have been identified that can modify disease progression. This unmet medical need is likely attributed to an incomplete understanding of the molecular mechanism driving disease development. To investigate the pathophysiology leading to AS, reliable and reproducible animal models that mimic human pathophysiology are needed. We have tested and expanded the protocols of a wire-injury induced AS mouse model. For this model, coronary wires were used to apply shear stress to the aortic valve cusps with increasing intensity. These protocols allowed distinction of mild, moderate and severe wire-injury. Upon moderate or severe injury, AS developed with a significant increase in aortic valve peak blood flow velocity. While moderate injury promoted solitary AS, severe-injury induced mixed aortic valve disease with concomitant mild to moderate aortic regurgitation. The changes in aortic valve function were reflected by dilation and hypertrophy of the left ventricle, as well as a decreased left ventricular ejection fraction. Histological analysis revealed the classic hallmarks of human disease with aortic valve thickening, increased macrophage infiltration, fibrosis and calcification. This new mouse model of AS promotes functional and morphological changes similar to moderate and severe human AS. It can be used to investigate the pathomechanisms contributing to AS development and to test novel therapeutic strategies.

Entities:  

Keywords:  Animal models; Aortic valve stenosis; Calcification; Inflammation

Mesh:

Year:  2019        PMID: 30767058     DOI: 10.1007/s00392-019-01413-1

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  29 in total

Review 1.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

2.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

Authors:  B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

3.  Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.

Authors:  Raj R Makkar; Gregory P Fontana; Hasan Jilaihawi; Samir Kapadia; Augusto D Pichard; Pamela S Douglas; Vinod H Thourani; Vasilis C Babaliaros; John G Webb; Howard C Herrmann; Joseph E Bavaria; Susheel Kodali; David L Brown; Bruce Bowers; Todd M Dewey; Lars G Svensson; Murat Tuzcu; Jeffrey W Moses; Matthew R Williams; Robert J Siegel; Jodi J Akin; William N Anderson; Stuart Pocock; Craig R Smith; Martin B Leon
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

4.  Extracellular matrix remodeling and organization in developing and diseased aortic valves.

Authors:  Robert B Hinton; Joy Lincoln; Gail H Deutsch; Hanna Osinska; Peter B Manning; D Woodrow Benson; Katherine E Yutzey
Journal:  Circ Res       Date:  2006-04-27       Impact factor: 17.367

5.  Incidence and progression of aortic valve calcium in the Multi-ethnic Study of Atherosclerosis (MESA).

Authors:  David S Owens; Ronit Katz; Junichiro Takasu; Richard Kronmal; Matthew J Budoff; Kevin D O'Brien
Journal:  Am J Cardiol       Date:  2010-03-01       Impact factor: 2.778

6.  Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.

Authors:  Gian M Novaro; Ronit Katz; Ronnier J Aviles; John S Gottdiener; Mary Cushman; Bruce M Psaty; Catherine M Otto; Brian P Griffin
Journal:  J Am Coll Cardiol       Date:  2007-10-29       Impact factor: 24.094

7.  Notch1 represses osteogenic pathways in aortic valve cells.

Authors:  Vishal Nigam; Deepak Srivastava
Journal:  J Mol Cell Cardiol       Date:  2009-08-18       Impact factor: 5.000

8.  A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice.

Authors:  Marie-Claude Drolet; Elise Roussel; Yves Deshaies; Jacques Couet; Marie Arsenault
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

9.  In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany.

Authors:  Helge Möllmann; Kurt Bestehorn; Maike Bestehorn; Konstantinos Papoutsis; Eckart Fleck; Georg Ertl; Karl-Heinz Kuck; Christian Hamm
Journal:  Clin Res Cardiol       Date:  2016-01-30       Impact factor: 5.460

10.  Animal models of calcific aortic valve disease.

Authors:  Krista L Sider; Mark C Blaser; Craig A Simmons
Journal:  Int J Inflam       Date:  2011-08-02
View more
  6 in total

1.  FIFA World Cup 2018: effect of emotional stress on conventional heart rate variability metrics.

Authors:  Wolfgang Hamm; Viktoria Bogner-Flatz; Axel Bauer; Stefan Brunner
Journal:  Clin Res Cardiol       Date:  2019-08-06       Impact factor: 5.460

2.  S2 Heart Sound Detects Aortic Valve Calcification Independent of Hemodynamic Changes in Mice.

Authors:  Valentina Dargam; Hooi Hooi Ng; Sana Nasim; Daniel Chaparro; Camila Iansen Irion; Suhas Rathna Seshadri; Armando Barreto; Zachary C Danziger; Lina A Shehadeh; Joshua D Hutcheson
Journal:  Front Cardiovasc Med       Date:  2022-05-25

3.  Multiparametric MRI identifies subtle adaptations for demarcation of disease transition in murine aortic valve stenosis.

Authors:  Christine Quast; Frank Kober; Katrin Becker; Elric Zweck; Jasmina Hoffe; Christoph Jacoby; Vera Flocke; Isabella Gyamfi-Poku; Fabian Keyser; Kerstin Piayda; Ralf Erkens; Sven Niepmann; Matti Adam; Stephan Baldus; Sebastian Zimmer; Georg Nickenig; Maria Grandoch; Florian Bönner; Malte Kelm; Ulrich Flögel
Journal:  Basic Res Cardiol       Date:  2022-05-29       Impact factor: 12.416

4.  Optical coherence tomography and multiphoton microscopy offer new options for the quantification of fibrotic aortic valve disease in ApoE-/- mice.

Authors:  Anett Jannasch; Christian Schnabel; Roberta Galli; Saskia Faak; Petra Büttner; Claudia Dittfeld; Sems Malte Tugtekin; Edmund Koch; Klaus Matschke
Journal:  Sci Rep       Date:  2021-03-12       Impact factor: 4.379

5.  PTP1B Inhibition Improves Mitochondrial Dynamics to Alleviate Calcific Aortic Valve Disease Via Regulating OPA1 Homeostasis.

Authors:  Feng Liu; Jinyong Chen; Wangxing Hu; Chenyang Gao; Zhiru Zeng; Si Cheng; Kaixiang Yu; Yi Qian; Dilin Xu; Gangjie Zhu; Jing Zhao; Xianbao Liu; Jian'an Wang
Journal:  JACC Basic Transl Sci       Date:  2022-07-25

Review 6.  Models and Techniques to Study Aortic Valve Calcification in Vitro, ex Vivo and in Vivo. An Overview.

Authors:  Maria Bogdanova; Arsenii Zabirnyk; Anna Malashicheva; Daria Semenova; John-Peder Escobar Kvitting; Mari-Liis Kaljusto; Maria Del Mar Perez; Anna Kostareva; Kåre-Olav Stensløkken; Gareth J Sullivan; Arkady Rutkovskiy; Jarle Vaage
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.